Josep M. Miró

1.6k total citations
39 papers, 877 citations indexed

About

Josep M. Miró is a scholar working on Infectious Diseases, Epidemiology and Archeology. According to data from OpenAlex, Josep M. Miró has authored 39 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 11 papers in Epidemiology and 7 papers in Archeology. Recurrent topics in Josep M. Miró's work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (6 papers). Josep M. Miró is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (6 papers). Josep M. Miró collaborates with scholars based in Spain, Denmark and United Kingdom. Josep M. Miró's co-authors include Josep Mallolas, María Eugenia Valls, Felipe García, Josep M. Gatell, E Soriano, Josep M. Gatell, J G SanMiguel, Bonaventura Clotet, Laura Zamora and Joan A. Caylà and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Josep M. Miró

36 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep M. Miró Spain 18 560 438 209 108 80 39 877
Ana González-Cordón Spain 17 459 0.8× 215 0.5× 237 1.1× 166 1.5× 100 1.3× 73 903
Thanomsak Anekthananon Thailand 14 546 1.0× 409 0.9× 193 0.9× 79 0.7× 109 1.4× 29 757
É. Rouveix France 15 464 0.8× 458 1.0× 184 0.9× 123 1.1× 35 0.4× 77 948
Sarika Desai United Kingdom 14 502 0.9× 539 1.2× 150 0.7× 121 1.1× 82 1.0× 25 877
B Gazzard United Kingdom 22 647 1.2× 477 1.1× 319 1.5× 220 2.0× 22 0.3× 49 1.4k
J Carswell Uganda 12 529 0.9× 316 0.7× 197 0.9× 100 0.9× 46 0.6× 30 919
Hopkins Dr United States 3 462 0.8× 339 0.8× 275 1.3× 114 1.1× 29 0.4× 8 1000
Pradeep A. Menon India 19 637 1.1× 449 1.0× 77 0.4× 55 0.5× 84 1.1× 41 957
Susanne Doblecki‐Lewis United States 18 669 1.2× 654 1.5× 79 0.4× 56 0.5× 38 0.5× 56 950
Mathurin Cyrille Tejiokem Cameroon 18 481 0.9× 386 0.9× 206 1.0× 61 0.6× 39 0.5× 69 815

Countries citing papers authored by Josep M. Miró

Since Specialization
Citations

This map shows the geographic impact of Josep M. Miró's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep M. Miró with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep M. Miró more than expected).

Fields of papers citing papers by Josep M. Miró

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep M. Miró. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep M. Miró. The network helps show where Josep M. Miró may publish in the future.

Co-authorship network of co-authors of Josep M. Miró

This figure shows the co-authorship network connecting the top 25 collaborators of Josep M. Miró. A scholar is included among the top collaborators of Josep M. Miró based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep M. Miró. Josep M. Miró is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martín-Iguacel, Raquel, Juliana Reyes‐Urueña, Andreu Bruguera, et al.. (2022). Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study. EClinicalMedicine. 52. 101600–101600. 17 indexed citations
2.
Lledó, Gema M., Jacobo Sellarés, Carlos Brotons, et al.. (2021). Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition. Clinical Microbiology and Infection. 28(3). 315–318. 22 indexed citations
3.
Martí, Marc, Felipe García, Christian Manzardo, et al.. (2015). Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study. BMC Public Health. 15(1). 1015–1015. 36 indexed citations
4.
Garriga, César, Felipe García, Josep M. Miró, et al.. (2015). Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort. PLoS ONE. 10(12). e0145701–e0145701. 25 indexed citations
5.
Gastaca, Mikel, Fernando Agüero, Antoni Rimola, et al.. (2012). Liver Retransplantation in HIV-Infected Patients: A Prospective Cohort Study. American Journal of Transplantation. 12(9). 2465–2476. 9 indexed citations
6.
León, Agathe, Cesar A. Cáceres, Maite de Blas, et al.. (2011). A New Multidisciplinary Home Care Telemedicine System to Monitor Stable Chronic Human Immunodeficiency Virus-Infected Patients: A Randomized Study. PLoS ONE. 6(1). e14515–e14515. 66 indexed citations
7.
Jaén, Ángeles, Anna Esteve, Josep M. Miró, et al.. (2008). Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2). 212–220. 44 indexed citations
8.
Gómez, Marı́a, Elena del Cacho, Carles Codina, et al.. (2007). Reacciones adversas del tratamiento antirretroviral: relación entre los síntomas percibidos y el cumplimiento terapéutico. Medicina Clínica. 129(4). 127–133. 12 indexed citations
9.
Moreno, Santiago, Javier Ariza, D Podzamczer, et al.. (1998). Brucellosis in patients infected with the human immunodeficiency virus. European Journal of Clinical Microbiology & Infectious Diseases. 17(5). 319–326. 34 indexed citations
10.
Valls, María Eugenia, JM Bordas, J.M. Piqué, et al.. (1997). [Chronic enteropathy of unknown etiology in patients with AIDS. An analysis of 40 cases].. PubMed. 109(12). 452–6. 5 indexed citations
11.
Miró, Josep M.. (1996). Continuidad o ruptura entre los tecnocomplejos líticos del VI al V milenio BC: la contribución de las industrias líticas del V milenio BC de la Cataluña Meridional. 139–150. 1 indexed citations
12.
Miró, Josep M.. (1995). La cultura material del Neolític Antic a la Conca de Barberà. Pyrenae: revista de prehistòria i antiguitat de la Mediterrània Occidental. 39–52. 3 indexed citations
13.
Miró, Josep M.. (1994). La cronologia dels estils ceràmics neolítics a Catalunya i la datació de C14 de la Timba del Barenys (Riudoms, Tarragona). SHILAP Revista de lepidopterología. 27(27). 57–66. 4 indexed citations
14.
Mallolas, Josep, Laura Zamora, Josep M. Gatell, et al.. (1993). Primary prophylaxis for Pneumocystis carinii pneumonia. AIDS. 7(1). 59–64. 37 indexed citations
16.
Miró, Josep M., et al.. (1991). El marc històric i arqueològic dels orígens de l'agricutura a Catalunya. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 77–87. 2 indexed citations
17.
Álvarez, Rosa, et al.. (1990). Haematogenous Serratia marcescens endophthalmitis in an HIV-infected intravenous drug addict. Infection. 18(1). 29–30. 16 indexed citations
18.
Bisbe, Josep, Josep M. Miró, Javiera Torres, et al.. (1989). Diagnostic Value of Serum Antibody .and Antigen Detection in Heroin Addicts with Systemic Candidiasis. Clinical Infectious Diseases. 11(2). 310–315. 14 indexed citations
19.
Bisbe, Josep, Josep M. Miró, Asunción Moreno, & Josep Mensa. (1987). Candida albicans endocarditis possibly related to systemic candidiasis in a heroin addict. European Journal of Clinical Microbiology & Infectious Diseases. 6(6). 657–658. 6 indexed citations
20.
Miró, Josep M., et al.. (1986). Excavaciones en el lado norte de la iglesia de Sant Marti (Lleida) Época andalusí y medieval. Dialnet (Universidad de la Rioja). 313–330. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026